Programmable Veterinary Biologics™
Engineering a new chapter in animal health
BiomEdit engineers bacteria to deliver precise, targeted biologic activity. Our Programmable Veterinary Biologics platform aims to prevent and treat disease across animal species.
Explore our pipelineWho we are
At BiomEdit, we develop engineered microbial biologics to improve animal health. Located inside the laboratory facilities of the Indiana Biosciences Research Institute, our experienced team works together to advance our Programmable Veterinary Biologics platform. From scientists and researchers to product developers and regulatory experts, we are building a new category in animal health.
Our goal: better outcomes for animals, producers, and veterinarians through practical solutions.
Discover our science
What we do
Our Programmable Veterinary Biologics platform combines microbial discovery, strain engineering, computational biology, and product development. We engineer beneficial bacteria to perform targeted biological functions. We can also selectively target bacteria directly from the microbiome. Each precise scientific technique provides a broader set of tools to address important animal health and production challenges for producers and veterinarians.
The result: products designed to fit into existing care and management practices for five species.
Strain Engineering
CPerf LLV* (formerly known as BE-101), is our lead product from our platform, developed for the prevention of necrotic enteritis in poultry. It establishes a regulatory and development path that can be applied to additional products.
BiomElix® One (BEX1) is a second proof point, acquired through Folium Science and approved for use in Brazil as an ingredient for use in feed additives. We are working on the feed additive registration to improve growth performance in chickens. BEX1 works in the presence of Salmonella.
Computational Biology
We use sequencing, computational biology, and AI/ML to characterize microbial communities, identify candidate strains, design payloads, and inform product design and development.
Proprietary Microbial Strain Library
Our microbial strain library spans a wide range of species, giving us a broad starting point for identifying and engineering strains suited to specific species, targets, and applications.
Pipeline
From discovery to commercial launch.
Lead Program — Infectious Disease
CPerf LLV*
Our lead Programmable Veterinary Biologic, developed to prevent necrotic enteritis in poultry through targeted delivery of nanobodies against C. perfringens toxins.
Learn moreConditional USDA licensure received. Commercial launch Q4 2026.
"We believe programmable biologics will become an important therapeutic modality across species. Our job is to turn that potential into products that work in the real world."
Aaron Schacht, CEO, BiomEdit
Our experience behind the science.
At BiomEdit, our team combines expertise in microbiology, computational biology, strain engineering, product development, regulatory affairs, and commercialization. Many have worked together for years, delivering results across human and animal health, multiple organizations, products, and species.
Latest from BiomEdit.
View all news
Interested in working with BiomEdit?
All third-party trademarks, service marks, trade names, trade dress, product names, and logos appearing on this page—including Anterra Capital, Viking Global Investors, Betagro Ventures, Elevate Ventures, Nutreco, AgriZeroNZ, Bill & Melinda Gates Foundation, Elanco, USDA, NIH, Ginkgo Bioworks, Ferment, TechPoint, and S&P Global—are the property of their respective owners. Their display on this site does not imply endorsement, sponsorship, or affiliation except as formally contracted.
*Clostridium Perfringens Alpha Toxin and NetB Antibody Fragment, Live Limosilactobacillus Vector